Volume 6, Issue 1 (6-1999)                   RJMS 1999, 6(1): 11-16 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sadjadi S J, Soltani Arabshahi S K, Asadi K. Effect of Rifampin and Cloxacilline on Staph. Aureus Nasal Carriers. RJMS. 1999; 6 (1) :11-16
URL: http://rjms.iums.ac.ir/article-1-1777-en.html
Abstract:   (5972 Views)

45 health personnels who were nasal carriers of staph aureus entered in this trial, seven subjects were omitted for various reesos, remainders randomly divided to 3 groups and were treated orally for 4 days.

- group I with rifampin & cloxacilline

- group 1/ with rifampin & placebo

- group 11/ with cloxacilline & placebo

All subjects were recultured 3 ~eeks after the completion of treatment.

In group I, all 14 subjects were culture negative (100% cure), in group 1/10 out of 14 were culture negative (71% cure) and, in group 11/5 out of 10 (50%), were cultur negative.

K.K statistical analysis method gave a P<0.017.

For comparison of three groups mamm-whitny test was used that yeilded following results:

- difference between group I & 1/ (P<0.033)29%

- difference between group I & II/(P< 0.036) 50%

- difference between group 1/ & 11/ (P<0.29)29%

In conclusion, oral use of rifampin and cloxacilline for four days is a suitable combination for treatment of staph aureus carriers.

*(comparision between the use of rifampin and cloxacillin alone was not possible due to low number of subjects)

Full-Text [PDF 1214 kb]   (1136 Downloads)    
Type of Study: Research | Subject: Internal Medicine

Add your comments about this article : Your username or Email:

© 2020 All Rights Reserved | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb